Ameritas Investment Partners, Inc. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18,494
-34.4%
4,2810.0%0.00%0.0%
Q2 2023$28,212
-2.9%
4,2810.0%0.00%0.0%
Q1 2023$29,068
-11.4%
4,2810.0%0.00%0.0%
Q4 2022$32,792
-21.9%
4,2810.0%0.00%
-50.0%
Q3 2022$42,000
-8.7%
4,2810.0%0.00%0.0%
Q2 2022$46,000
-4.2%
4,2810.0%0.00%0.0%
Q1 2022$48,000
-28.4%
4,2810.0%0.00%0.0%
Q4 2021$67,000
-8.2%
4,2810.0%0.00%
-33.3%
Q3 2021$73,000
-20.7%
4,2810.0%0.00%0.0%
Q2 2021$92,000
+43.8%
4,2810.0%0.00%
+50.0%
Q1 2021$64,000
+14.3%
4,2810.0%0.00%
-33.3%
Q4 2020$56,000
+36.6%
4,2810.0%0.00%
+50.0%
Q3 2020$41,000
-16.3%
4,2810.0%0.00%0.0%
Q2 2020$49,000
+11.4%
4,2810.0%0.00%0.0%
Q1 2020$44,000
-37.1%
4,2810.0%0.00%
-33.3%
Q4 2019$70,000
+22.8%
4,2810.0%0.00%0.0%
Q3 2019$57,000
-5.0%
4,2810.0%0.00%0.0%
Q2 2019$60,000
-24.1%
4,2810.0%0.00%
-25.0%
Q1 2019$79,000
-29.5%
4,2810.0%0.00%
-33.3%
Q4 2018$112,000
+14.3%
4,2810.0%0.01%
+20.0%
Q3 2018$98,000
+32.4%
4,281
+10.7%
0.01%
+25.0%
Q2 2018$74,000
+13.8%
3,8660.0%0.00%
+33.3%
Q1 2018$65,000
+10.2%
3,8660.0%0.00%0.0%
Q4 2017$59,000
-10.6%
3,8660.0%0.00%0.0%
Q3 2017$66,000
+4.8%
3,8660.0%0.00%0.0%
Q2 2017$63,000
+57.5%
3,866
+35.4%
0.00%
+50.0%
Q1 2017$40,0002,8550.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders